1. |
|
|
2. |
- Gripenberg, Sofia, et al.
(författare)
-
Seed polyphenols in a diverse tropical plant community
- 2018
-
Ingår i: Journal of Ecology. - : Wiley. - 0022-0477. ; 106:1, s. 87-100
-
Tidskriftsartikel (refereegranskat)abstract
- Polyphenols are one of the most common groups of secondary metabolites in plants and thought to play a key role in enhancing plant fitness by protecting plants against enemies. Although enemy-inflicted mortality at the seed stage can be an important regulator of plant populations and a key determinant of community structure, few studies have assessed community-level patterns of polyphenol content in seeds. We describe the distribution of the main seed polyphenol groups across 196 tree and liana species on Barro Colorado Island (Panama) and community-level patterns in two aspects of their biological activity (protein precipitation and oxidative capacity). Taking advantage of substantial variation in morphological and ecological traits in the studied plant community, we test for correlations and trade-offs between seed polyphenols and nonchemical plant traits hypothesised to make plant species more or less likely to invest in polyphenol production. The majority of species have polyphenols in their seeds. The incidence and concentrations of polyphenols were related to a set of nonchemical plant traits. Polyphenols were most likely to be present (and where present, to be expressed in high concentrations) in species with large seeds, short seed dormancy times, low investment in mechanical seed defences, high wood density, high leaf mass per area, tough leaves and slow growth rates. Synthesis. Our study reveals a potential trade-off between chemical and mechanical seed defences and shows that plant species that invest in physical defences at later life stages (high wood density and tough leaves) tend not to invest in physical defences of seeds but instead produce secondary metabolites likely to act as seed defences. Overall, our results conform to predictions from the resource availability hypothesis, which states that species in resource-limited environments (such as slow-growing shade-tolerant tree species) will invest more in defences than fast-growing pioneer species.
|
|
3. |
- Askling, J., et al.
(författare)
-
How comparable are rates of malignancies in patients with rheumatoid arthritis across the world? A comparison of cancer rates, and means to optimise their comparability, in five RA registries
- 2016
-
Ingår i: Annals of the Rheumatic Diseases. - : BMJ. - 0003-4967 .- 1468-2060. ; 75:10, s. 1789-1796
-
Tidskriftsartikel (refereegranskat)abstract
- Background The overall incidence of cancer in patients with rheumatoid arthritis (RA) is modestly elevated. The extent to which cancer rates in RA vary across clinical cohorts and patient subsets, as defined by disease activity or treatment is less known but critical for understanding the safety of existing and new antirheumatic therapies. We investigated comparability of, and means to harmonise, malignancy rates in five RA registries from four continents. Methods Participating RA registries were Consortium of Rheumatology Researchers of North America (CORRONA) (USA), Swedish Rheumatology Quality of Care Register (SRR) (Sweden), Norfolk Arthritis Register (NOAR) (UK), CORRONA International (several countries) and Institute of Rheumatology, Rheumatoid Arthritis (IORRA) (Japan). Within each registry, we analysed a main cohort of all patients with RA from January 2000 to last available data, and sensitivity analyses of sub-cohorts defined by disease activity, treatment change, prior comorbidities and restricted by calendar time or follow-up, respectively. Malignancy rates with 95% CIs were estimated, and standardised for age and sex, based on the distributions from a typical RA clinical trial programme population (fostamatinib). Results There was a high consistency in rates for overall malignancy excluding non-melanoma skin cancer (NMSC), for malignant lymphomas, but not for all skin cancers, across registries, in particular following age/sex standardisation. Standardised rates of overall malignancy excluding NMSC varied from 0.56 to 0.87 per 100 person-years. Within each registry, rates were generally consistent across sensitivity analyses, which differed little from the main analysis. Conclusion In real-world RA populations, rates of both overall malignancy and of lymphomas are consistent.
|
|
4. |
|
|
5. |
- Davies, Thomas G., et al.
(författare)
-
Open data and digital morphology.
- 2017
-
Ingår i: Proceedings of the Royal Society of London. Biological Sciences. - : The Royal Society. - 0962-8452 .- 1471-2954. ; 284:1852, s. 1-10
-
Tidskriftsartikel (refereegranskat)abstract
- Over the past two decades, the development of methods for visualizing and analysing specimens digitally, in three and even four dimensions, has transformed the study of living and fossil organisms. However, the initial promise that the widespread application of such methods would facilitate access to the underlying digital data has not been fully achieved. The underlying datasets for many published studies are not readily or freely available, introducing a barrier to verification and reproducibility, and the reuse of data. There is no current agreement or policy on the amount and type of data that should be made available alongside studies that use, and in some cases are wholly reliant on, digital morphology. Here, we propose a set of recommendations for minimum standards and additional best practice for three-dimensional digital data publication, and review the issues around data storage, management and accessibility.
|
|
6. |
- Garwood, Nancy C., et al.
(författare)
-
Trema domingensis rises like a phoenix from the ashes of Trema integerrima : A reassessment of the entire-leaved species of Neotropical Trema (Cannabaceae)
- 2018
-
Ingår i: Journal of the Botanical Research Institute of Texas. - : Botanical Research Institute of Texas. - 1934-5259 .- 2644-1608. ; 12:2, s. 555-577
-
Tidskriftsartikel (refereegranskat)abstract
- We resolve three problems concerning the three entire-leaved species of Neotropical Trema. 1) Phylogenetic and morphological results showed that T. integerrima (Beurl.) Standl., T. domingensis Urb., and T. laxiflora Lundell are a single species; therefore, we combine them under a single name. 2) The date of publication gives priority to T. integerrima, as the basionym Sponia integerrima Beurl. was published in 1856. However, the type specimen, Billberg 308 (S), is not a species of Trema but Pouzolzia obliqua (Wedd.) Wedd. (Urticaceae); therefore, Sponia integerrima Beurl. is a new synonym of P. obliqua. The next available name for the entire-leaved species is T. domingensis, published in1912. 3) The type of T. domingensis, Fuertes 312, is a mixed collection. Specimens of Fuertes 312 held at B, NY, U, and USD are T. domingensis, while those at P, G, US, and Z are Celtis trinervia Lam. We provide a historical review to understand how these problems arose and persisted unnoticed for decades.
|
|
7. |
|
|
8. |
- Michaud, K., et al.
(författare)
-
Can rheumatoid arthritis (RA) registries provide contextual safety data for modern RA clinical trials? The case for mortality and cardiovascular disease
- 2016
-
Ingår i: Annals of the Rheumatic Diseases. - : BMJ. - 0003-4967 .- 1468-2060. ; 75:10, s. 1797-1805
-
Tidskriftsartikel (refereegranskat)abstract
- Background We implemented a novel method for providing contextual adverse event rates for a randomised controlled trial (RCT) programme through coordinated analyses of five RA registries, focusing here on cardiovascular disease (CVD) and mortality. Methods Each participating registry (Consortium of Rheumatology Researchers of North America (CORRONA) (USA), Swedish Rheumatology Quality of Care Register (SRR) (Sweden), Norfolk Arthritis Register (NOAR) (UK), CORRONA International (East Europe, Latin America, India) and Institute of Rheumatology, Rheumatoid Arthritis (IORRA) (Japan)) defined a main cohort from January 2000 onwards. To address comparability and potential bias, we harmonised event definitions and defined several subcohorts for sensitivity analyses based on disease activity, treatment, calendar time, duration of follow-up and RCT exclusions. Rates were standardised for age, sex and, in one sensitivity analysis, also HAQ. Results The combined registry cohorts included 57251 patients with RA (234089 person-years)24.5% men, mean (SD) baseline age 58.2 (13.8) and RA duration 8.2 (11.7) years. Standardised registry mortality rates (per 100 person-years) varied from 0.42 (CORRONA) to 0.80 (NOAR), with 0.60 for RCT patients. Myocardial infarction and major adverse cardiovascular events (MACE) rates ranged from 0.09 and 0.31 (IORRA) to 0.39 and 0.77 (SRR), with RCT rates intermediate (0.18 and 0.42), respectively. Additional subcohort analyses showed small and mostly consistent changes across registries, retaining reasonable consistency in rates across the Western registries. Additional standardisation for HAQ returned higher mortality and MACE registry rates. Conclusions This coordinated approach to contextualising RA RCT safety data demonstrated reasonable differences and consistency in rates for mortality and CVD across registries, and comparable RCT rates, and may serve as a model method to supplement clinical trial analyses for drug development programmes.
|
|
9. |
- Reinke, Beth A, et al.
(författare)
-
Diverse aging rates in ectothermic tetrapods provide insights for the evolution of aging and longevity
- 2022
-
Ingår i: Science. - : American Association for the Advancement of Science. - 0036-8075 .- 1095-9203. ; 376:6600, s. 1459-1466
-
Tidskriftsartikel (refereegranskat)abstract
- Comparative studies of mortality in the wild are necessary to understand the evolution of aging; yet, ectothermic tetrapods are underrepresented in this comparative landscape, despite their suitability for testing evolutionary hypotheses. We present a study of aging rates and longevity across wild tetrapod ectotherms, using data from 107 populations (77 species) of nonavian reptiles and amphibians. We test hypotheses of how thermoregulatory mode, environmental temperature, protective phenotypes, and pace of life history contribute to demographic aging. Controlling for phylogeny and body size, ectotherms display a higher diversity of aging rates compared with endotherms and include phylogenetically widespread evidence of negligible aging. Protective phenotypes and life-history strategies further explain macroevolutionary patterns of aging. Analyzing ectothermic tetrapods in a comparative context enhances our understanding of the evolution of aging.
|
|
10. |
- Verstappen, S. M. M., et al.
(författare)
-
Methodological Challenges When Comparing Demographic and Clinical Characteristics of International Observational Registries
- 2015
-
Ingår i: Arthritis Care & Research. - : Wiley. - 2151-464X .- 2151-4658. ; 67:12, s. 1637-1645
-
Tidskriftsartikel (refereegranskat)abstract
- Objective. Comparisons of data from different registries can be helpful in understanding variations in many aspects of rheumatoid arthritis (RA). The study aim was to assess and improve the comparability of demographic, clinical, and comorbidity data from 5 international RA registries. Methods. Using predefined definitions, 2 subsets of patients (main cohort and subcohort) from 5 international observational registries (Consortium of Rheumatology Researchers of North America Registry [CORRONA], the Swedish Rheumatology Quality of Care Register [SRR], the Norfolk Arthritis Register [NOAR], the Institute of Rheumatology Rheumatoid Arthritis cohort [IORRA], and CORRONA International) were evaluated and compared. Patients ages >18 years with RA, and present in or recruited to the registry from January 1, 2000, were included in the main cohort. Patients from the main cohort with positive rheumatoid factor and/or erosive RA who had received >= 1 synthetic disease-modifying antirheumatic drug (DMARD), and switched to or added another DMARD, were included in the subcohort at time of treatment switch. Results. Age and sex distributions were fairly similar across the registries. The percentage of patients with a high Disease Activity Score in 28 joints score varied between main cohorts (17.5% IORRA, 18.9% CORRONA, 24.7% NOAR, 27.7% CORRONA International, and 36.8% SRR), with IORRA, CORRONA, and CORRONA International including more prevalent cases of RA; the differences were smaller for the subcohort. Prevalence of comorbidities varied across registries (e.g., coronary artery disease ranged from 1.5% in IORRA to 7.9% in SRR), partly due to the way comorbidity data were captured and general cultural differences; the pattern was similar for the subcohorts. Conclusion. Despite different inclusion criteria for the individual RA registries, it is possible to improve the comparability and interpretability of differences across RA registries by applying well-defined cohort definitions.
|
|